SCHEMBL6813664

SCHEMBL6813664

[CH2]COC(=O)O[C@H]1CCc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.49
HTR2C P28335 1/20 0.42
OPRM1 P35372 1/20 0.42
DRD3 P35462 1/20 0.42
AVPR1A P37288 1/20 0.42
OPRK1 P41145 1/20 0.42
FFAR1 O14842 3/20 0.40
CTSV O60911 1/20 0.40
CTSL P07711 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
PIN1 Q13526 2/20 0.38
CHRM4 P08173 2/20 0.37
DRD2 P14416 2/20 0.37
HTR7 P34969 2/20 0.37
GPR84 Q9NQS5 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29590253 0.86 IDO1 (0.59) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL11142136 0.86 IDO1 (0.59) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL12989536 0.85 IDO1 (0.49) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL29855606 0.85 IDO1 (0.49) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL31564976 0.79 IDO1 (0.51) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL8308445 0.78 IDO1 (0.58) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL817976 0.76 IDO1 (0.56) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL2175357 0.76 IDO1 (0.61) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL30908530 0.76 IDO1 (0.56) IDO1HTR2COPRM1DRD3AVPR1A
SCHEMBL28735117 0.76 IDO1 (0.62) IDO1CTSVCTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040266673-A1 Long lasting natriuretic peptide derivatives CONJUCHEM INC (CA) 2004-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266673-A1 Long lasting natriuretic peptide derivatives NPPA, NPR1, NPR3 IDO1 3670/4885HTR2C 3515/4885OPRM1 1912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.